Harnessing the potential of artificial intelligence (AI), scientists have made significant strides in preemptively identifying future virus strains, which is crucial for vaccine development.
A collaborative effort between the University of Oxford and Harvard Medical School has led to the creation of EVEscape, a groundbreaking model that accurately predicts virus mutations in response to human immune defences.
This innovative AI tool has shown potential in forecasting the evolutionary paths of viruses, thereby aiding in the strategic design of vaccines tailored to combat these future variants. The University of Oxford proudly states that this technology is akin to “predicting the future,” highlighting its revolutionary impact on the field of virology.
Tremendous Value
Pascal Notin, who co-led the study, stated that the model could have precisely forecasted the predominant mutations of COVID-19 had it been applied from the pandemic’s outset.
“This work is of tremendous value, both for pandemic surveillance efforts, but also to inform vaccine design in a way that is robust to the emergence of certain at-risk mutations,” he added.
The COVID-19 pandemic was significantly affected by the emergence of numerous virus variants, each with distinct genetic mutations that influenced their transmissibility and interaction with the human immune system. The Omicron variant, which surfaced in late 2021, serves as a prime example, infecting millions worldwide while fortunately not causing a proportional increase in hospitalizations and fatalities.
EVEscape
EVEscape, short for Evolutionary Model of Variant Effect, is a sophisticated blend of deep-learning algorithms and extensive biological data, which together predict the probability of a virus developing mutations that allow it to elude immune responses, such as hindering antibody binding. The research team, in their publication in the journal Nature, detailed the workings of EVEscape and emphasized its role in anticipating viral mutations.
The effectiveness of EVEscape was proven when it was put to the test using data solely available at the onset of the COVID-19 pandemic in February 2020. The model not only successfully forecasted the mutations of the SARS-CoV-2 virus but also identified which variants would dominate. Additionally, it highlighted the potential reduction in efficacy of antibody-based treatments as the virus evolved.
The anticipation is that this AI-driven technology will play a pivotal role in future preventative strategies, guiding the development of vaccines that proactively target concerning virus variants before they become widespread. The research team envisions EVEscape providing tremendous value in our ongoing battle against viral diseases and enhancing our preparedness for potential future pandemics.
